FLT3LG and neoplasm: Therefore, we speculated that Flt3L, as an upstream cytokine for prostate carcinogenesis, is the basis for its ability to act as a cellular tumor adjuvant, while be regarded as a downstream cytokine for prostate carcinogenesis, Flt3L could inhibit local tumor infiltration and distant metastasis.[48–50]